SOTHEMA (CAS:SOT) Notes Receivable: MAD0 Mil (As of Dec. 2025)


CAS:SOT SOTHEMA CAS:SOT
73 GF Score
Price MAD379.50
GF Value MAD284.90
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is SOTHEMA Notes Receivable?

SOTHEMA CAS:SOT -0.12% 73 Notes Receivable is MAD0 Mil as of Dec. 2025. GuruFocus rates CAS:SOT with a GF Score™ of 73/100 and a GF Value™ of MAD284.90 (Significantly Overvalued). The stock has 6 warning signs investors should review.

SOTHEMA's Notes Receivable for the quarter that ended in Dec. 2025 was MAD0 Mil.

SOTHEMA Notes Receivable Historical Data

* Premium members only.

The historical data trend for SOTHEMA's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOTHEMA Notes Receivable Chart

SOTHEMA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SOTHEMA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CAS:SOT
73GF Score
SOTHEMA CAS:SOT
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SOTHEMA Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of MAD0 Mil mean?
SOTHEMA (CAS:SOT) has a Notes Receivable of MAD0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on SOTHEMA and its competitors.
Is SOTHEMA's Notes Receivable too high?
SOTHEMA's current Notes Receivable is MAD0 Mil. Overall, SOTHEMA has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOTHEMA's Notes Receivable compare to LLY and JNJ?
SOTHEMA's Notes Receivable of MAD0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on SOTHEMA and its competitors. SOTHEMA's current Notes Receivable is MAD0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOTHEMA stock overvalued right now?
Based on GuruFocus' analysis, SOTHEMA (CAS:SOT) is currently considered Significantly Overvalued. The stock's GF Value™ is MAD284.90, compared to a current price of MAD379.50 — trading 33.2% above its estimated fair value. The current Notes Receivable is MAD0 Mil. SOTHEMA's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For SOTHEMA (CAS:SOT), the current Notes Receivable is MAD0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SOTHEMA (CAS:SOT) Overvalued in 2026?

Based on GuruFocus' analysis, SOTHEMA stock appears to be overvalued. The current stock price of MAD379.50 is trading 33.2% above its estimated GF Value™ of MAD284.90. GuruFocus considers SOTHEMA to be Significantly Overvalued.

Key valuation signals for CAS:SOT:

  • Notes Receivable: MAD0 Mil
  • GF Value™: MAD284.90 vs. price of MAD379.50 (33.2% above fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the CAS:SOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SOTHEMA Business Description

Address Centre de Bouskoura, BP no. 1, Casablanca, MAR
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.
73GF Score

Get the complete analysis for CAS:SOT

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MAD379.50
Price
MAD284.90
GF Value